Shots: The SURPASS-4 study evaluates the efficacy & safety of tirzepatide (5/10/15mg) vs insulin glargine in 2002 adults in a ratio (1:1:1:3) with T2D inadequately controlled with 1 & up […]readmore
Tags : The Lancet
Shots: The SURPASS-1 study involves assessing the efficacy & safety of Tirzepatide as monothx. (5/10/15 mg) vs PBO in 478 patients in the ratio (1:1:1:1) with T2D inadequately controlled with […]readmore
Shots: The P-III AURORA 1 study involves assessing the efficacy and safety of Lupkynis (23.7mg, bid) + MMF and low-dose corticosteroids vs MMF and low-dose corticosteroids alone in 357 adults […]readmore
Shots: The P-IIIb Liberty study involves assessing of Aimovig (140 mg) vs PBO @12 wks. in patients with episodic migraine (4 to 14 migraine days/month) P-IIIb LIBERTY study results: reduction […]readmore